Patients with Rare Autoimmune Rheumatic Disease Face More Severe COVID-19 Cases

A review of COVID-19 data from the UK shows that patients with rare autoimmune rheumatic disease (RAIRD) face a higher mortality risk, according to an article in Healio. The study,…

Continue Reading Patients with Rare Autoimmune Rheumatic Disease Face More Severe COVID-19 Cases
ACR Convergence 2020: Presentations on KZR-616 for Autoimmune Conditions
https://pixabay.com/photos/student-typing-keyboard-text-woman-849822/

ACR Convergence 2020: Presentations on KZR-616 for Autoimmune Conditions

Since the company was founded, biotechnology company Kezar Life Sciences ("Kezar") has worked to develop therapies for patients with oncologic and autoimmune disorders. Recently, they highlighted a potential treatment, KZR-616,…

Continue Reading ACR Convergence 2020: Presentations on KZR-616 for Autoimmune Conditions
Experimental Drug Earns Orphan Drug Designation for Polymyositis and Dermatomyositis
source: pixabay.com

Experimental Drug Earns Orphan Drug Designation for Polymyositis and Dermatomyositis

According to a story from Biotech 365, the biotechology company Kezar Life Sciences, Inc. recently announced that its experimental therapy KZR-616 has earned Orphan Drug designations from the US Food…

Continue Reading Experimental Drug Earns Orphan Drug Designation for Polymyositis and Dermatomyositis
ICYMI: Phase 3 Study for Dermatomyositis has Completed Enrollment
source: pixabay.com

ICYMI: Phase 3 Study for Dermatomyositis has Completed Enrollment

Corbus Pharmaceuticals has just announced that participant enrollment for their Phase 3 trial of lenabasum for dermatomyositis has been completed. Dermatomyositis Dermatomyositis (DM) is a rare autoimmune disease. It can…

Continue Reading ICYMI: Phase 3 Study for Dermatomyositis has Completed Enrollment

Researchers Find Effective Biomarker for Predicting Severity of Myositis-Associated Interstitial Lung Disease

A team of researchers recently evaluated a new biomarker in interstitial lung disease to see whether or not it could predict disease severity and ultimately mortality. The Biomarker Surfactant protein…

Continue Reading Researchers Find Effective Biomarker for Predicting Severity of Myositis-Associated Interstitial Lung Disease
No Improvement in Mortality Rate for Idiopathic Inflammatory Myositis
source: pixabay.com

No Improvement in Mortality Rate for Idiopathic Inflammatory Myositis

The medical field has seen many advancements over the past few decades. In particular, treatment for rheumatic diseases has greatly improved. However, states Healio, this is not reflected in patient…

Continue Reading No Improvement in Mortality Rate for Idiopathic Inflammatory Myositis

Myositis Research Could Aid in COVID-19 Vaccine Development

Myositis Myositis is an autoimmune disease that leads to muscle damage. Patients live with chronic disability due to the symptoms of this rare condition. These include skin rashes, pain, weakness, fatigue,…

Continue Reading Myositis Research Could Aid in COVID-19 Vaccine Development
Firma Clinical Research Incorporates Patient “Lived Experience” Into Training Materials
5239640 / Pixabay

Firma Clinical Research Incorporates Patient “Lived Experience” Into Training Materials

According to a story from outsourcing-pharma.com, the company Firma Clinical Research, which provides health care services to patients in clinical trials, has been getting a lot of business lately. This…

Continue Reading Firma Clinical Research Incorporates Patient “Lived Experience” Into Training Materials
Researchers Continue Search for Role of Type-1 Interferon Pathway in Rheumatic Disease
mohamed_hassan / Pixabay

Researchers Continue Search for Role of Type-1 Interferon Pathway in Rheumatic Disease

According to a publication from the Rheumatologist, past studies have suggested that type 1 interferons may play a significant role in determining susceptibility to several classic connective tissue diseases. Although…

Continue Reading Researchers Continue Search for Role of Type-1 Interferon Pathway in Rheumatic Disease

The Myositis Association (TMA) to Host 2017 Annual Patient Conference

The Myositis Association (TMA) supports the myositis community, helps to fund myositis research and increases myositis awareness. Registration is currently OPEN for their 2017 Annual Patient Conference. Details below: Who: The…

Continue Reading The Myositis Association (TMA) to Host 2017 Annual Patient Conference